Neoadjuvant chemotherapy vs upfront surgery for gastric signet ring cell carcinoma: A retrospective, propensity score-matched study

doi:10.3748/wjg.v26.i8.818

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 26, Issue 8

This Article

Academic Content and Language Evaluation of This Article

CrossCheck and Google Search of This Article

Academic Rules and Norms of This Article

Citation of this article

Corresponding Author of This Article

Research Domain of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Number of Hits and Downloads for This Article

Total Article Views (10371)

All Articles published online

The chart showing PDF series, WORD series, HTML series, Figures (1-2) series, Tables (1-5) series.

Item

Count

PDF

557

WORD

215

HTML

6208

Figures (1-2)

654

Tables (1-5)

280

Sum=7914

Publishing Process of This Article

The chart showing Browse series, Download series.

Item

Count

Browse

880

Download

1577

Sum=2457

Feb 28, 2020 (publication date) through Nov 8, 2024

Times Cited of This Article

Times Cited (26)

Journal Information of This Article

Publication Name

World Journal of Gastroenterology

ISSN

1007-9327

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Retrospective Study

World J Gastroenterol. Feb 28, 2020; 26(8): 818-827
Published online Feb 28, 2020. doi: 10.3748/wjg.v26.i8.818

Open in New Tab Full Size Figure Download Figure

Figure 1 Gastric signet-ring cell carcinoma characterized by the presence of classical signet-ring cells (A, H&E, 20×; B, H&E, 40×).

Open in New Tab Full Size Figure Download Figure

Figure 2 Comparison of overall survival. A: Comparison of overall survival between neoadjuvant chemotherapy and surgery-first before propensity score matching; B: Cumulative survival rates between neoadjuvant chemotherapy and surgery-first after propensity score matching. There was no statistically significant difference between the two groups. NAC: Neoadjuvant chemotherapy.

Citation: Li Y, Ma FH, Xue LY, Tian YT. Neoadjuvant chemotherapy vs upfront surgery for gastric signet ring cell carcinoma: A retrospective, propensity score-matched study. World J Gastroenterol 2020; 26(8): 818-827
URL: https://www.wjgnet.com/1007-9327/full/v26/i8/818.htm
DOI: https://dx.doi.org/10.3748/wjg.v26.i8.818